AzTrials
AzTrials

Autism Spectrum Disorder (ASD)PPiANCT06659731

Quantitative Sensory Testing to Study Pain Perception in Autism

An observational study of Autism Spectrum Disorder (ASD) and Pain Perception, run by IRCCS Eugenio Medea at 1 site in Italy.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study aims at assess sensory perception, and pain perception, in neurodivergent children and adolescent in the autism spectrum. To achieve this goal, the quantitive sensory testing (QST), a controlled and replicable protocol, will be used, to assess perception in different sensory modalities: heat sensations… Read more about this study

Who is it for?
Ages 5 to 17 yearsHealthy volunteers can take part
What is being tested?
Quantitative Sensory testing (QST) and EEG
How many people
50 participants
Where
1 siteItaly
Study dates
17 Jul 2024to Sep 2025
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 5 to 17 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Study population: Children and adolescent between 5 and 17 years old

Who may be able to join

  • Children and adolescent
  • age between 5 and 17 years old
  • Autism diagnosis according to DSM-V criteria
  • healthy children and adolescent (without neurological, and psychiatric, diagnoses)
  • age between 5 and 17 years old

Who cannot join

  • Comorbidities with (for the clinical sample) or diagnosis of (for the control sample):
  • peripheral neuropaties;
  • psychiatric diagnosis as psychosis,
  • Tourette Syndrome,
  • neurological diagnoses as epilepsy,
  • sensory deficit or loss;
  • genetic diseases

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Italy1 site, 1 recruiting
  • IRCCS "E. Medea"

    Brindisi, BR, 72100

    Valentina Nicolardi, 0039 3200598331, valentina.nicolardi@lanostrafamiglia.it

    valentina nicolardi, PhD

    Recruiting

Other trials in Italy

About this study

Official title: Pain Perception in Autism. Study Through Quantitative Sensory Testing and Psychophysiological Correlates

This study aims at assess sensory perception, and pain perception, in neurodivergent children and adolescent in the autism spectrum. To achieve this goal, the quantitive sensory testing (QST), a controlled and replicable protocol, will be used, to assess perception in different sensory modalities: heat sensations, mechanical detection threshold and pain threshold. As secondary aim, the cortical processing of thermal painful stimuli will be collected through electroencephalography (EEG) in order to investigate if there are differences in the cortical processing of painful stimuli between clinical sample and control sample, and if it could be associated with differences in the subjective experience between the two groups. Finally, it will be explored the association between such differences, and indexes of psychopathology and dispositional measures.

Read the detailed description

Study procedure imply the following steps: 1. Eligibility assessment according to inclusion and exclusion criteria. 2. Administration of questionnaires and scales for the characterization of clinical aspects of autism: Short sensory profile; The Autism Spectrum Quotient: Children's Version; Vineland Adaptive Behaviour Scales-Second Edition. The Vineland Adaptive Behaviour Scales-Second Edition; The Child Behavior Checklist (CBCL). 3. Administration of Quantitative Sensory Testing to study sensory thresholds and perception. 4. EEG recording at rest as well as while receiving heat stimuli to study cortical processing of salient thermal stimuli.

The QST protocol, implies the administration of 7 short sensory test in order to measure up to 13 parameters, which can be grouped as follows: thermal detection thresholds for the perception of cold, warm and paradoxical heat sensations, thermal pain thresholds for cold and hot stimuli, mechanical detection thresholds for touch and vibration, mechanical pain thresholds and sensitivity for pinprick and blunt pressure, vibration detection threshold and pressure pain threshold. Previous research with QST in neurodevelopmental disorders used modified version of the whole protocol, to make it suitable and tolerable for different clinical condition such as developmental delay including motor, communicative, and cognitive impairments. Thus, we will also administer the most suitable and tolerable version of the QST according to each patient condition and needs, for example we plan to reduce the number of stimuli for each stimulation side when needed, in order to reduce stimulus trial duration as well. The whole procedure will be implemented in a kids friendly environment, colourful and comfortable, and sensory stimuli will be adapted in order to avoid fearfulness of the stimuli, thus each stimulation will be presented as a game to be played with a specific animal, and each device and instrument will be covered with animals pictures according to the game it represents. Overall QST last about 1h 30 minutes, it will be divided in at least two sessions according to patients' needs.

The EEG recording consist in the cap montage at first, then a short accommodation with the sensory stimuli in order to find an intensity value for a moderate painful stimulus, to be used for the stimulation. After the preparation/accommodation, the eeg recording will start while a series, up to 30 thermal stimuli, will be delivered to the patients' hand dorsum. The whole eeg recording last about 30 minutes and it will be implemented in one session only.

Being tested
Quantitative Sensory testing (QST), EEG
Keywords
autism spectrum disorder (ASD), pain perception, somatosensory profile, children, QST
Medical subject headings
Autism Spectrum Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Quantitative Sensory testing (QST)Other

    The QST protocol (Rolke et al., 2006; Blankenburg et al., 2010), implies the administration of 7 short sensory test in order to measure up to 13 parameters, which can be grouped as follows: thermal detection thresholds for the perception of cold, warm and paradoxical heat sensations, thermal pain thresholds for cold and hot stimuli, mechanical detection thresholds for touch and vibration, mechanical pain thresholds and sensitivity for pinprick and blunt pressure, vibration detection threshold and pressure pain threshold.

  • EEGOther

    EEG recording at rest and while receiving heat stimuli to study cortical processing of salient thermal stimuli. Up to 30 painful thermal stimuli, will be delivered to the patients' hand dorsum in order to register contact heat evoked potentials (CHEPs).

Study groups in NCT06659731
Study groupRoleWhat they receive
ASD GroupPatients with ASD diagnosis according to DSM-V, between 5 and 17 years old
Receives: Other: Quantitative Sensory testing (QST); Other: EEG
Control GroupHealthy participants, between 5 and 17 years old, without ASD diagnosis and withour neurological and psychiatric deseases
Receives: Other: Quantitative Sensory testing (QST); Other: EEG

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. EEG responses in the time domain

    ERPs amplitude (μV)

    Measured: from the enrollment to the end of EEG recordin (approx. 3 days)

  2. Cold detection threshold

    The minimum intensity value (°C) at which a cold stimulus is perceived by each participant

    Measured: from the enrollment to the end of QST administration (approx. 2 days)

  3. Warm detection threshold

    The minimum intensity value (°C) at which a warm stimulus is perceived by each participant

    Measured: from the enrollment to the end of QST administration (approx. 2 days)

  4. Cold pain threshold

    The minimum intensity value (°C) at which a cold stimulus is perceived as painful by each participant

    Measured: from the enrollment to the end of QST administration (approx. 2 days)

  5. Warm pain threshold

    The minimum intensity value (°C) at which a warm stimulus is perceived as painful by each participant

    Measured: from the enrollment to the end of QST administration (approx. 2 days)

  6. Mechanical detection threshold

    The minimum intensity value (mN) at which a mechanical stimulus is perceived by each participant. It is a measure of touch perception

    Measured: from the enrollment to the end of QST administration (approx. 2 days)

  7. Mechanical pain threshold

    The minimum intensity value (mN) at which a mechanical stimulus is perceived as painful by each participant.

    Measured: from the enrollment to the end of QST administration (approx. 2 days)

  8. Vibration detection threshold

    The minimum intensity value (Hz) at which a vibratory stimulus is perceived by each participant.

    Measured: from the enrollment to the end of QST administration (approx. 2 days)

  9. Pressure pain threshold

    The minimum intensity value (N) at which a pressure stimulus is perceived as painful by each participant.

    Measured: from the enrollment to the end of QST administration (approx. 2 days)

  10. EEG responses in the time-frequency domain

    Power-spectrum of eeg responses

    Measured: from the enrollment to the end of QST administration (approx. 3 days)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Oct 2024
  2. Study start17 Jul 2024
  3. Primary completionJul 2025 (estimated)
  4. Study completionSep 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06659731
Sponsor's protocol ID
id. 1043
Acronym
PPiA
Status last verified
Oct 2024
First submitted
14 Oct 2024
Last updated
26 Oct 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Hoffman T, Bar-Shalita T, Granovsky Y, Gal E, Kalingel-Levi M, Dori Y, Buxbaum C, Yarovinsky N, Weissman-Fogel I. Indifference or hypersensitivity? Solving the riddle of the pain profile in individuals with autism. Pain. 2023 Apr 1;164(4):791-803. doi: 10.1097/j.pain.0000000000002767. Epub 2022 Aug 26.

    PubMed 36730631
  • Vaughan S, McGlone F, Poole H, Moore DJ. A Quantitative Sensory Testing Approach to Pain in Autism Spectrum Disorders. J Autism Dev Disord. 2020 May;50(5):1607-1620. doi: 10.1007/s10803-019-03918-0.

    PubMed 30771132
  • Chien YL, Chao CC, Wu SW, Hsueh HW, Chiu YN, Tsai WC, Gau SS, Hsieh ST. Small fiber pathology in autism and clinical implications. Neurology. 2020 Nov 10;95(19):e2697-e2706. doi: 10.1212/WNL.0000000000010932. Epub 2020 Oct 14.

    PubMed 33055277
  • Frundt O, Grashorn W, Schottle D, Peiker I, David N, Engel AK, Forkmann K, Wrobel N, Munchau A, Bingel U. Quantitative Sensory Testing in adults with Autism Spectrum Disorders. J Autism Dev Disord. 2017 Apr;47(4):1183-1192. doi: 10.1007/s10803-017-3041-4.

    PubMed 28160223
  • ZHANG Wenyun LX, YAO Junjie, YE Qian, PENG Weiwei. Abnormalities in pain sensitivity among individuals with autism spectrum disorder: Evidence from meta-analysis. Acta Psychologica Sinica 2021;53(6):613-628

  • Proff I, Williams GL, Quadt L, Garfinkel SN. Sensory processing in autism across exteroceptive and interoceptive domains. Psychology & Neuroscience 2022;15(2):105

  • Moore DJ. Acute pain experience in individuals with autism spectrum disorders: a review. Autism. 2015 May;19(4):387-99. doi: 10.1177/1362361314527839. Epub 2014 Mar 31.

    PubMed 24687688
  • Nicolardi V, Fanizza I, Accogli G, Scoditti S, Trabacca A. Pain perception in autism. A study of sensory reactivity in children and adolescents with autism using quantitative sensory testing and psychophysiological correlates. Front Neurosci. 2025 May 1;19:1543538. doi: 10.3389/fnins.2025.1543538. eCollection 2025.

    PubMed 40376609

Questions about this trial

What is this clinical trial studying?

An observational study of Autism Spectrum Disorder (ASD) and Pain Perception, run by IRCCS Eugenio Medea at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 26 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Valentina Nicolardi, PhD (0039 3200598331, valentina.nicolardi@lanostrafamiglia.it), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

EEG responses in the time domain (time frame: from the enrollment to the end of EEG recordin (approx. 3 days)). The study lists 10 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06659731, which also lists 8 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Oct 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in